OOIR: Observatory of International Research

Papers

(The H4-Index of Heart Rhythm is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Implantable cardioverter-defibrillators for primary prevention during or early after hospitalization? A time to pause, reflect, and exercise sound clinical judgment	359
14-3-3ε/YWHAE regulates the transcriptional expression of cardiac sodium channel NaV1.5	201
ID: 4121707 The Benefit of Signal Quality Assessment in Automated Ventricular Ectopic Beat Detection	197
Decisional conflict and defibrillator implantation choices among Black women and men with chronic systolic heart failure	182
Outcome of cardiac implantable electronic devices in pediatric heart transplant recipients	119
To the Editor — Ganglionated plexus modulation inducing vagal response during pulsed field ablation for atrial fibrillation: A blessing in disguise	115
Efficacy and safety of once-daily carvedilol in patients with atrial fibrillation: A randomized, double-blind, placebo-controlled trial	111
Cardiac resynchronization therapy with triple fusion using the SyncAV dynamic algorithm compared to conventionally optimized biventricular pacing: Results from the multicentric, randomized, double-bli	111
Access to electrophysiologic care for Medicare beneficiaries across the United States: Travel distance and time to nearest clinician, 2013–2020	92
Age-stratified outcomes of transvenous lead extraction: A 5090-patient experience from the ExTRACT registry	85
Managing vagal responses induced by pulsed field ablation: Go right first?	84
PO-04-170 AUTOMATED CT-BASED PREDICTION OF VENTRICULAR ARRHYTHMIA	81
PO-03-146 PREMATURE VENTRICULAR CONTRACTIONS IN CHILDREN AND YOUNG ADULTS: RISK FACTORS FOR LEFT VENTRICULAR DYSFUNCTION	81
PO-04-066 DESIGN AND PRE-CLINICAL ASSESSMENT OF A NOVEL RETROGRADE AORTIC DELIVERY SHEATH TO AID ACCESS FOR LEFT VENTRICULAR MAPPING AND ABLATION	81
CI-452767-3 MACHINE LEARNING-POWERED, DEVICE-EMBEDDED HEART SOUND MEASUREMENT CAN OPTIMIZE AV DELAY IN CRT PATIENTS	79
PO-02-216 SEGMENTAL INCREASE IN HETEROGENEITY OF REPOLARIZATION CORRESPONDS TO REGIONS OF DECREASED INNERVATION AFTER MYOCARDIAL INFARCTION	73
PO-05-119 PEAK FREQUENCY CAN BE EFFECTIVELY USED TO CHARACTERIZE ATRIAL REMODELING IN ATRIAL FIBRILLATION	72
PO-04-196 CORRELATION BETWEEN VENTRICULAR TACHYCARDIA CIRCUIT AND CARDIAC COMPUTED TOMOGRAPHY-DERIVED WALL THINNING FOR POSTINFARCTION VENTRICULAR TACHYCARDIA ABLATION	64
PO-01-043 COMPARISON OF RISK SCORES FOR PREDICTION OF SUDDEN DEATH AND SUSTAINED VENTRICULAR TACHYCARDIA IN REPAIRED TETRALOGY OF FALLOT	64
PO-01-141 REAL LIFE EXPERIENCE WITH PULSED FIELD ABLATION FOR RECURRENT VENTRICULAR ARRHYTHMIAS	58
PO-01-065 DECREASE IN HEART RATE AND BRADYCARDIA PRECEDING IN-HOSPITAL CARDIAC ARREST	56
PO-01-019 VASCULAR AGE PREDICTION USING CHEST X-RAYS	56
PO-04-122 PULSED FIELD ABLATION DOSE-RESPONSE SAFETY AND EFFICACY CHARACTERIZATION OF A NOVEL LARGE SPHERICAL TIP MAPPING AND CONTACT FORCE-SENSING CATHETER	55
PO-04-064 INVASIVE HAEMODYNAMIC ASSESSMENT SHOWS THE OBESITY-HFPEF PHENOTYPE IS COMMON AMONGST PATIENTS WITH SYMPTOMATIC AF	53
PO-03-160 IS THERE A FUTURE FOR THE 90-DAY BLANKING PERIOD AFTER PULSED FIELD ABLATION: EARLY RECURRENCES IN THE PULSED AF TRIAL	52

PO-01-079 SEX DIFFERENCES IN ELECTROGRAPHIC FLOW PHENOTYPES AND OUTCOMES IN PATIENTS UNDERGOING PULMONARY VEIN ISOLATION	51
PO-01-093 PREDICTORS OF ARRHYTHMIA IN THE INPATIENT POPULATION PRIMARILY HOSPITALIZED FOR SARS-COV-2; A RETROSPECTIVE LARGE-DATABASE ANALYSIS	49
PO-01-026 RIGHT ATRIAL APPENDAGE THROMBECTOMY USING ALPHAVAC TO FACILITATE ATRIAL FIBRILLATION (AFIB) ABLATION	45
PO-02-144 LEFT ATRIAL FUNCTIONAL AND TISSUE CHANGES AFTER PULMONARY VEIN ISOLATION IN ATRIAL FIBRILLATION PATIENTS - INITIAL RESULTS OF THE EVALUATE-PVI STUDY	44
PO-02-140 WITHDRAWN	42
MP-483499-007 MECHANISMS OF MITRAL ISTHMUS RECONNECTION AFTER MITRAL ISTHMUS ABLATION WITH AND WITHOUT VEIN OF MARSHALL ETHANOL INFUSION	42
PO-03-174 PREDICTORS OF PERMANENT PACEMAKER PLACEMENT IN PATIENTS UNDERGOING TRICUSPID VALVE SURGERY-A RETROSPECTIVE COHORT STUDY OF THE NATIONAL INPATIENT SAMPLE	42
PO-03-192 THE ASSOCIATION BETWEEN PACED LEFT VENTRICULAR ACTIVATION TIME AND CARDIAC REVERSE REMODELING IN HEART FAILURE PATIENTS WITH LEFT BUNDLE BRANCH BLOCK	41
PO-03-171 LEADLESS PACEMAKERS ARE UNAFFECTED BY RADIATION EXPOSURE AT CLINICALLY RELEVANT THERAPEUTIC DOSES USED IN ONCOLOGY	41
PO-02-064 IS THORACIC IMPEDANCE TRULY ACCURATE IN PREDICTING ACUTE DECOMPENSATIONS ACROSS DIFFERENT STAGES OF HEART FAILURE?	39
PO-02-192 FIRST REPORT OF STRENGTH-DURATION CURVES OBTAINED FROM PATIENTS IMPLANTED WITH A NOVEL DUAL-CHAMBER LEADLESS PACEMAKER SYSTEM	39
PO-03-164 INCIDENCE, PREDICTORS, AND INDICATIONS FOR PERMANENT PACEMAKER IMPLANTATION AFTER ORTHOTOPIC HEART TRANSPLANTATION	39
PO-02-069 OUTCOMES OF LEFT BUNDLE BRANCH AREA PACING UPGRADE IN PATIENTS WITH RIGHT VENTRICULAR PACING-INDUCED CARDIOMYOPATHY	37
PO-01-036 ACCURACY OF FORWARD-SOLUTION COMPUTATIONAL ECG MAPPING FOR VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH ADULT CONGENITAL HEART DISEASE	37